Jiangxi Sanxin MedtecLtd Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Jiangxi Sanxin MedtecLtd.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth	26.3%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Investors Shouldn't Be Too Comfortable With Jiangxi Sanxin MedtecLtd's (SZSE:300453) Earnings

Oct 21

Jiangxi Sanxin Medtec Co.,Ltd.'s (SZSE:300453) Price Is Right But Growth Is Lacking After Shares Rocket 37%

Oct 08

Returns Are Gaining Momentum At Jiangxi Sanxin MedtecLtd (SZSE:300453)

Sep 30

Jiangxi Sanxin MedtecLtd (SZSE:300453) Is Due To Pay A Dividend Of CN¥0.15

Apr 23

Jiangxi Sanxin Medtec Co.,Ltd.'s (SZSE:300453) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Apr 04

Concerns Surrounding Jiangxi Sanxin MedtecLtd's (SZSE:300453) Performance

Mar 29

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Jiangxi Sanxin MedtecLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SZSE:300453 - Analysts future estimates and past financials data (CNY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
9/30/2024	1,452	233	188	454	N/A
6/30/2024	1,405	223	97	378	N/A
3/31/2024	1,358	215	122	410	N/A
12/31/2023	1,300	207	52	340	N/A
9/30/2023	1,281	184	218	482	N/A
6/30/2023	1,258	169	172	413	N/A
3/31/2023	1,287	182	118	352	N/A
1/1/2023	1,336	185	192	402	N/A
9/30/2022	1,322	184	86	257	N/A
6/30/2022	1,315	189	160	336	N/A
3/31/2022	1,240	169	169	338	N/A
1/1/2022	1,164	156	155	330	N/A
9/30/2021	1,085	148	150	305	N/A
6/30/2021	1,013	142	115	249	N/A
3/31/2021	1,014	138	146	257	N/A
12/31/2020	940	116	175	273	N/A
9/30/2020	922	104	190	290	N/A
6/30/2020	870	89	172	263	N/A
3/31/2020	759	69	109	218	N/A
12/31/2019	722	62	44	167	N/A
9/30/2019	639	52	-47	102	N/A
6/30/2019	573	42	-100	72	N/A
3/31/2019	547	40	-122	40	N/A
12/31/2018	531	41	-74	59	N/A
9/30/2018	487	40	-53	50	N/A
6/30/2018	465	39	N/A	39	N/A
3/31/2018	441	42	N/A	61	N/A
12/31/2017	404	42	N/A	63	N/A
9/30/2017	378	37	N/A	68	N/A
6/30/2017	351	38	N/A	71	N/A
3/31/2017	324	34	N/A	55	N/A
12/31/2016	318	37	N/A	61	N/A
9/30/2016	305	47	N/A	53	N/A
6/30/2016	303	47	N/A	69	N/A
3/31/2016	310	51	N/A	81	N/A
12/31/2015	312	52	N/A	63	N/A
9/30/2015	322	51	N/A	63	N/A
6/30/2015	324	50	N/A	56	N/A
3/31/2015	323	49	N/A	N/A	N/A
12/31/2014	322	49	N/A	68	N/A
12/31/2013	305	49	N/A	30	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 300453's forecast earnings growth is above the savings rate (2.8%).

Earnings vs Market: Insufficient data to determine if 300453's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 300453's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 300453's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 300453's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 300453's Return on Equity is forecast to be high in 3 years time

Jiangxi Sanxin MedtecLtd Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Investors Shouldn't Be Too Comfortable With Jiangxi Sanxin MedtecLtd's (SZSE:300453) Earnings

Third quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.10 in 3Q 2023)

Jiangxi Sanxin Medtec Co.,Ltd.'s (SZSE:300453) Price Is Right But Growth Is Lacking After Shares Rocket 37%

Jiangxi Sanxin Medtec Co.,Ltd. to Report Q3, 2024 Results on Oct 15, 2024

Investor sentiment improves as stock rises 24%

Returns Are Gaining Momentum At Jiangxi Sanxin MedtecLtd (SZSE:300453)

Jiangxi Sanxin Medtec Co.,Ltd. Announces Interim Profit Distribution Plan to Be Implemented on A Shares for the Year 2024, Payable on 09 September 2024

Second quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.087 in 2Q 2023)

Jiangxi Sanxin Medtec Co.,Ltd. to Report First Half, 2024 Results on Jul 26, 2024

Now 23% undervalued

Jiangxi Sanxin MedtecLtd (SZSE:300453) Is Due To Pay A Dividend Of CN¥0.15

Dividend of CN¥0.15 announced

Jiangxi Sanxin Medtec Co.,Ltd.'s (SZSE:300453) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Jiangxi Sanxin Medtec Co.,Ltd. to Report Q1, 2024 Results on Apr 17, 2024

Concerns Surrounding Jiangxi Sanxin MedtecLtd's (SZSE:300453) Performance

Full year 2023 earnings released: EPS: CN¥0.40 (vs CN¥0.36 in FY 2022)

Jiangxi Sanxin Medtec Co.,Ltd., Annual General Meeting, Apr 16, 2024

Jiangxi Sanxin Medtec Co.,Ltd. (SZSE:300453) announces an Equity Buyback for CNY 60 million worth of its shares.

Investor sentiment deteriorates as stock falls 19%

Jiangxi Sanxin Medtec Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 23, 2024

Third quarter 2023 earnings released: EPS: CN¥0.10 (vs CN¥0.074 in 3Q 2022)

Jiangxi Sanxin Medtec Co.,Ltd. to Report Q3, 2023 Results on Oct 21, 2023

Second quarter 2023 earnings released: EPS: CN¥0.087 (vs CN¥0.11 in 2Q 2022)

Jiangxi Sanxin Medtec Co.,Ltd. to Report First Half, 2023 Results on Aug 05, 2023

First quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.093 in 1Q 2022)

Now 21% undervalued

Full year 2022 earnings released: EPS: CN¥0.47 (vs CN¥0.40 in FY 2021)

Insufficient new directors

Third quarter 2022 earnings released: EPS: CN¥0.096 (vs CN¥0.11 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.094 in 2Q 2021)

Jiangxi Sanxin Medtec Co.,Ltd. Announces Final Cash Dividend for 2021, Payable on 29 April 2022

High number of new directors

Jiangxi Sanxin Medtec Co.,Ltd. Announces Cash Dividend for 2021

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.095 in 3Q 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS CN¥0.094 (vs CN¥0.076 in 2Q 2020)

Investor sentiment deteriorated over the past week

First quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.05 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.45 (vs CN¥0.24 in FY 2019)

Investor sentiment deteriorated over the past week

Full year 2020 earnings released: EPS CN¥0.45 (vs CN¥0.24 in FY 2019)

New 90-day high: CN¥18.61

Jiangxi Sanxin Medtec Co.,Ltd. to Report Fiscal Year 2020 Results on Mar 27, 2021

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

New 90-day low: CN¥15.92

Third quarter earnings released

Jiangxi Sanxin Medtec Co.,Ltd. to Report Q3, 2020 Results on Oct 19, 2020

New 90-day low - CN¥17.05

Earnings released

New 90-day high - CN¥24.73

Jiangxi Sanxin Medtec Co.,Ltd. to Report First Half, 2020 Results on Aug 19, 2020

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies